Global incidence and prevalence in uveal melanoma
- PMID: 39726825
- PMCID: PMC11670701
- DOI: 10.1016/j.aopr.2024.10.001
Global incidence and prevalence in uveal melanoma
Abstract
Purpose: The most common intraocular cancer in adults is uveal melanoma (UM). This study aimed to investigate and report the incidence and prognosis of UM in different regions of the world.
Methods: We retrieved relevant data on UM from the PubMed database and analyzed its global incidence and prognosis. All data was obtained from a national population-based registry, with publication dates ranging from 2013 to 2023.
Results: The incidence rates of UM vary across different regions: in the United States, rates were 5.1 per million (1993-2008) and 5.2 per million (1973-2013); in Canada, rates ranged from 3.34 per million (1992-2010) to 5.09 per million (2011-2017); in Republic of Korea, the rate was 0.42 per million (1999-2011); in New Zealand, it was 5.56 per million (2000-2020); in Australia, it was 7.6 per million (1982-2014); and in Europe, rates ranged from 3.1 to 5.8 per million (1995-2002). Among European countries, Sweden (5.6 per million (1960-2009)), Germany (6.41 per million (2009-2015)), Poland (6.67 per million (2010-2017)), and the United Kingdom (10 per million (1999-2010)).
Conclusions: The most common site of occurrence for UM is in the choroid. Limited data suggest a stable trend in UM incidence rates across the included countries, but significant differences in incidence rates exist among different countries and regions, with notably lower rates in Asian countries compared to Europe, North America, and Oceania. In general, the incidence rate in males is slightly higher compared to that in females.
Keywords: Epidemiology; Incidence; Uveal melanoma.
© 2024 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Global Incidence and Trend of Uveal Melanoma from 1943-2015: A Meta-Analysis.Asian Pac J Cancer Prev. 2022 May 1;23(5):1791-1801. doi: 10.31557/APJCP.2022.23.5.1791. Asian Pac J Cancer Prev. 2022. PMID: 35633566 Free PMC article.
-
Incidence of uveal melanoma in Europe.Ophthalmology. 2007 Dec;114(12):2309-15. doi: 10.1016/j.ophtha.2007.01.032. Epub 2007 May 11. Ophthalmology. 2007. PMID: 17498805
-
Uveal melanoma incidence trends in Canada: a national comprehensive population-based study.Br J Ophthalmol. 2019 Dec;103(12):1872-1876. doi: 10.1136/bjophthalmol-2018-312966. Epub 2019 Feb 28. Br J Ophthalmol. 2019. PMID: 30819691
-
Uveal Melanoma in Asians: A Review.Ocul Oncol Pathol. 2021 Jun;7(3):159-167. doi: 10.1159/000512738. Epub 2021 Feb 9. Ocul Oncol Pathol. 2021. PMID: 34307326 Free PMC article. Review.
-
Liver metastasis in uveal melanoma - treatment options and clinical outcome.Front Biosci (Landmark Ed). 2022 Feb 21;27(2):72. doi: 10.31083/j.fbl2702072. Front Biosci (Landmark Ed). 2022. PMID: 35227015 Review.
Cited by
-
Estimating uveal melanoma volume with ellipsoid tumour models.Acta Ophthalmol. 2025 Sep;103(6):691-698. doi: 10.1111/aos.17492. Epub 2025 Apr 3. Acta Ophthalmol. 2025. PMID: 40176717 Free PMC article.
-
A Brief Overview of Uveal Melanoma Treatment Methods with a Focus on the Latest Advances.J Clin Med. 2025 Jun 8;14(12):4058. doi: 10.3390/jcm14124058. J Clin Med. 2025. PMID: 40565803 Free PMC article.
References
LinkOut - more resources
Full Text Sources